About: Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $72.40 (+0.88%)
SLGL NASDAQ Sol Gel Technologies Ltd
Sol Gel Technologies Ltd share price
SLGL price activity
Last Price
$72.400
Change (24hr)
0.63 USD (0.88%)
Volume
28.09K
Volume (4w avg)
-
Open
$71.77
Day Range
$71.77 - $72.41
Previous Close
$71.77
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
SLGL price performance
Delayed
12 Oct, 8:00 pm GMT+0
SLGL Market Signals